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This dissemination  study  examined  the effectiveness  of  therapist-assisted  Internet-delivered  Cognitive
Behavior  Therapy  (ICBT)  when  offered  in  clinical  practice.  A  centralized  unit  screened  and  coordinated
ICBT  delivered  by newly  trained  therapists  working  in  six geographically  dispersed  clinical  settings.
Using  an  open  trial design,  221  patients  were  offered  12  modules  of ICBT  for  symptoms  of  general-
ized  anxiety  (n =  112),  depression  (n =  83),  or panic  (n = 26).  At  baseline,  midpoint  and  post-treatment,
patients  completed  self-report  measures.  On  average,  patients  completed  8 of  12  modules.  Latentnternet-delivered
herapist-assisted
ognitive behavior therapy
epression
eneralized anxiety
anic
growth  curve  modeling  identiﬁed  signiﬁcant  reductions  in  depression,  anxiety,  stress  and impairment
(d  =  .65–.78),  and  improvements  in  quality  of  life  (d =  .48–.66).  Improvements  in  primary  symptoms  were
large  (d  = .91–1.25).  Overall,  therapist-assisted  ICBT  was  effective  when  coordinated  across  settings  in
clinical  practice,  but  further  attention  should  be  given  to strategies  to improve  completion  of  treatment
modules.
© 2014  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND∗ Corresponding author at: 3737 Wascana Parkway, Department of Psychology, Univers
E-mail addresses: hadjista@uregina.ca (H.D. Hadjistavropoulos), nicky.e.pugh@gmai
H. Hesser), gerhard.andersson@liu.se (G. Andersson), max.ivanov@uregina.ca (M.  Ivano
ordon.Asmundson@uregina.ca (G.J.G. Asmundson), brittklein@iinet.net.au (B. Klein), da
1 Tel.: +1 306 337 3331; fax: +1 306 337 3227.
2 Tel.: +1 306 337 3331; fax: +1 306 585 6263.
3 Tel.: +46 13 285845.
4 Tel.: +46 13 28 5840; fax: +46 13 28 21 45.
5 Tel.: +1 306 337 2133; fax: +1 306 585 4745.
6 Tel.: +1 306 585 4856; fax: +1 306 585 4745.
7 Tel.: +1 306 585 5464; fax: +1 306 585 5461.
8 Tel.: +1 306 337 2415; fax: +1 306 337 3227.
9 Tel.: +61 3 5327 6717.
10 Tel.: +61 3 925 17227.
ttp://dx.doi.org/10.1016/j.janxdis.2014.09.018
887-6185/© 2014 The Authors. Published by Elsevier Ltd. This is an open access article unlicense  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
ity of Regina, Regina, SK, Canada S4S 6J4. Tel.: +306 585 5133; fax: +1 306 337 3227.
l.com (N.E. Pugh), Marcie.Nugent@uregina.ca (M.M. Nugent), hugo.hesser@liu.se
v), butz@cs.uregina.ca (C.G. Butz), Greg.Marchildon@uregina.ca (G. Marchildon),
vid.austin@deakin.edu.au (D.W. Austin).
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
l of An
1
s
t
n
t
t
c
r
I
m
a
o
a
d
w
t
m
C
h
m
s
I
(
i
u
t
b
i
t
c
d
c
n
s
c
t
&
e
o
t
p
i
a
o
w
i
4
p
A
i
t
a
o
d
a
d
s
t
w
aH.D. Hadjistavropoulos et al. / Journa
. Introduction
Depression and anxiety are highly prevalent and associated with
igniﬁcant morbidity for the individual and substantial burden for
he health care system (Eaton et al., 2008). Internet-delivered cog-
itive behavior therapy (ICBT) represents a pragmatic approach
hat may  address common treatment barriers such as limited access
o mental health providers, unwillingness to disclose mental health
oncerns, and challenges seeking care due to limited time, rural or
emote residence, and or mobility difﬁculties (Andersson, 2009).
CBT involves reviewing psychoeducational materials presented in
odules over the Internet and is commonly paired with therapist-
ssistance provided by phone or secure messaging.
Over the past decade, research has demonstrated the efﬁcacy
f ICBT for the treatment of depression and anxiety disorders. In
 meta-analysis of 22 controlled studies that compared ICBT for
epression and anxiety with or without therapist assistance to a
aiting list control condition, effect size superiority over the con-
rol group was 0.88 and symptom improvement was shown to be
aintained after 26-weeks on average post-treatment (Andrews,
uijpers, Craske, McEvoy, & Titov, 2010). Results also indicated
igh levels of accessibility, adherence, and satisfaction with this
odality. Even more impressive is that several studies reported
imilar treatment outcomes when comparing therapist-assisted
CBT to face-to-face therapy for depression and anxiety disorders
Andersson, Cuijpers, Carlbring, Riper, & Hedman, in press).
Although the beneﬁts of ICBT have been ﬁrmly established
n controlled studies, the performance of this approach remains
nderstudied when delivered in routine clinical practice. Efﬁcacy
rials are typically conducted using strict protocols and delivered
y a small number of therapists within specialized treatment sett-
ngs. These trials often utilize extensive and strict exclusion criteria
hat are not representative of conditions evident in routine clini-
al practice. For wide-scale dissemination to occur, it is critical to
emonstrate the effectiveness of ICBT outside of highly controlled
linical trials (Streiner, 2002).
Preliminary evidence is encouraging regarding the effective-
ess of ICBT in routine clinical practice. For example, in a large
tudy, 1500 community patients were treated through a Dutch
linic offering therapist-assisted ICBT for depression, panic, post-
raumatic stress, and burnout (Ruwaard, Lange, Schrieken, Dolan,
 Emmelkamp, 2012). Results indicated that effect sizes and recov-
ry rates were comparable to, or somewhat superior than, those
bserved in previous controlled trials, and similar to those of face-
o-face CBT. Moreover, patients reported high satisfaction with the
rograms, with over 71% completing their programs, and symptom
mprovement sustained up to one year post-treatment. Ruwaard
nd colleagues (2012) noted the importance of examining ICBT in
ther clinical contexts. In a recent review of effectiveness studies, it
as found that ICBT appears to be effective when delivered in clin-
cal practice (Andersson & Hedman, 2013). The review included
 controlled trials and 8 open studies, involving a total of 3888
atients. However, studies have only been conducted in Sweden,
ustralia, and the Netherlands, indicating a need to evaluate ICBT
n other countries and settings.
In the present research, we describe the utilization and effec-
iveness of ICBT programs for depression, generalized anxiety,
nd panic disorder when delivered in clinical practice. The model
f delivery was unique with a centralized unit responsible for
eveloping and maintaining the ICBT web application, training
nd monitoring community therapists or supervised graduate stu-
ents working in one of six geographically dispersed clinics, and
creening and assigning self-referred or provider-referred patients
o therapists (Hadjistavropoulos et al., 2011). A centralized model
as implemented as this was considered more cost-efﬁcient with
 higher degree of oversight and quality control than if each clinicxiety Disorders 28 (2014) 884–893 885
worked independently. ICBT represented a new model of service
delivery in all clinics and hence the trial can be described as a dis-
semination project. The ICBT program content was  licensed from an
established virtual clinic in Australia (Klein, Meyer, Austin, & Kyrios,
2011). The objective of the study was to determine the external
validity of the ICBT programs when delivered in clinical practice in
this manner. We  expected that the treatment programs would pro-
duce moderate to large effects (Andersson & Hedman, 2013). We
also hypothesized that treatment satisfaction would be high. This
research is likely to assist with the transfer of knowledge to clinical
practice and may  encourage other community clinics to consider
implementing ICBT in clinical practice.
2. Methods
2.1. Design and ethics
This was an uncontrolled pre/post treatment study that was
approved by all review boards of the institutions involved. All
patients provided electronic informed consent that their pooled
data could be used for research purposes.
2.2. Participants and recruitment
The current sample comprised patients who requested ICBT
between October 2010 and April 2013. Patients were notiﬁed of
ICBT gradually over this time period as therapists were trained and
became available to provide services. Patients learned of the service
by means of community mental health clinics, family physicians,
media stories (e.g., radio, television, newspaper), online adver-
tisements on various web  pages, as well as word of mouth. In
order to access services, patients ﬁrst underwent a centralized
pre-screening telephone interview regarding demographic details,
computer and Internet access and use, and severity and chronicity
of symptoms.
Patients who  fulﬁlled the initial inclusion criteria were invited
to participate in a full-clinical interview. This telephone interview
consisted of the administration of the MINI International Neu-
ropsychiatric Interview (MINI; Sheehan et al., 1998), a structured
clinical interview assessing psychiatric disorders. The interviews,
conducted by the Unit coordinator and ﬁve trained clinical psychol-
ogy graduate students, determined whether patients met clinical
or subclinical criteria for major depressive episode, generalized
anxiety disorder, or panic disorder. As a clinical service, it was con-
sidered important to provide treatment to those with both clinical
and subclinical symptoms. Interviews were also used to rule out
exclusionary clinical problems where face-to-face services were
deemed more appropriate, including psychotic disorders, manic
episodes, alcohol or substance dependence or abuse, and suicide
plan and or intent.
A total of 379 adult patients completed pre-screening, with 221
offered ICBT for symptoms of generalized anxiety (n = 112), depres-
sion (n = 83), or panic (n = 26). Criteria for inclusion were: (a) being
at least 18 years of age; (b) residing in Saskatchewan, Canada; (c)
self-reported access to, and comfort using, a computer and the
Internet; (d) consent to notify a physician of their participation;
(e) if taking medication, stable dose for more than a month; (f) not
participating in other psychotherapy; (g) reporting no current or
recent problems with psychotic disorders, manic episodes, alcohol
or substance dependence or abuse, or suicide plan or intent; and
(h) symptoms of depression, generalized anxiety, or panic (deﬁned
as a total Patient Health Questionnaire-9 (PHQ-9; Kroenke, Spitzer,
& Williams, 2001) score above 5, Generalized Anxiety Disorder-7
(GAD-7; Spitzer, Kroenke, Williams, & Lowe, 2006) score above 5, or
Panic Disorder Severity Scale-Self Report (PDSS-SR; Houck, Spiegel,
886 H.D. Hadjistavropoulos et al. / Journal of Anxiety Disorders 28 (2014) 884–893
Table 1
Baseline characteristics of patients by program.
Characteristic Generalized anxiety (n = 112) Depression (n = 83) Panic (n = 26) Total sample (n = 221)
Age M (SD) 38.71 (11.87) 41.73 (13.27) 39.38 (16.28) 39.92 (13.00)
%  (n) % (n) % (n) % (n)
Sex
Female 64.3 (72) 74.7 (62) 73.1 (19) 69.2 (153)
Male  35.7(40) 25.3 (21) 26.9 (7) 30.8 (68)
Marital  status
Married/Common law 58.1 (65) 44.6 (37) 46.2 (12) 51.6 (114)
Single/Never married 37.5 (42) 45.8 (38) 42.3 (11) 41.2 (91)
Widowed/Divorced/Separated 4.5 (5) 9.6 (8) 11.5 (3) 7.2 (16)
Ethnicitya
Caucasian 94.6 (87) 96.6 (56) 88.9 (16) 94.6 (159)
Aboriginal 2.2 (2) 3.4 (2) 5.6 (1) 3.0 (5)
Other  3.3 (3) 0 (0) 5.6 (1) 2.4 (4)
Education
Less  than high school diploma 7.1 (8) 8.4 (7) 15.4 (4) 8.6 (19)
High  school diploma 15.2 (17) 18.1 (15) 19.2 (5) 16.7 (37)
College  35.7 (40) 47.0 (39) 38.5 (10) 40.3 (89)
University 41.9(47) 26.5 (22) 26.9 (7) 34.4 (76)
Employed
Yes  78.6 (88) 68.7 (57) 46.2 (12) 71.0 (157)
No  22.4 (24) 31.3 (26) 53.8 (14) 29.0 (64)
Geographic location
Large city (over 200,000) 49.1(55) 48.2 (40) 76.9 (20) 52.0 (115)
Small  city (10,000–200,000) 21.4(24) 24.1 (20) 7.6 (2) 20.8 (46)
Town/Village/Farm 29.5 (33) 27.7 (23) 15.3 (4) 27.1 (60)
Psychotropic medication
Yes 58.0 (65) 66.3 (55) 61.5 (16) 61.5 (136)
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to the patient. If the patient did not log-on during the week, the-No  42.0 (47) 
a Ethnicity was not collected from the ﬁrst 54 patients and was  thus only availab
hear, & Rucci, 2002) score above 6). Table 1 provides demographic
etails of the patients offered treatment.
A total of 158 patients were assessed as being ineligible for ICBT
or reasons including: (a) loss of contact during the screening pro-
ess or patient indicated loss of interest in participating (n = 62); (b)
eported recent or current problems with psychosis, manic episode,
lcohol or substance dependence or abuse, or suicide plan or intent
hich were outside the treatment scope (n = 32); (c) currently in
eceipt of psychotherapy (n = 26); (d) symptoms too mild (n = 19);
r (e) did not meet other inclusion criteria reported above (e.g.,
ge, residency, computer/Internet access; n = 19). When assessed as
neligible, patients were referred to services appropriate for their
oncerns.
.3. ICBT programs
The Online Therapy Unit for Service, Education and Research
www.onlinetherapyuser.ca) coordinated access to ICBT programs
or depression, generalized anxiety, and panic. The Unit was devel-
ped in 2010 to serve residents of Saskatchewan. Program content
as licensed from existing evidence-based ICBT programs devel-
ped by Swinburne University of Technology National eTherapy
entre in Australia (see Klein et al., 2011 for a review). Each online
rogram is comprised of 12 modules that are primarily text-based,
ut also include graphics, audio (e.g., to demonstrate deep breath-
ng), and video (e.g., to demonstrate cognitive restructuring) to
upplement the material. All programs begin with psychoeducation
bout the targeted disorder, followed by modules that address cog-
itive (e.g., identifying and challenging thoughts) and behavioral
e.g., relaxation, problem-solving, exposure, behavioral activation)
trategies for managing the disorder. A relapse prevention mod-
le concludes each program. Check-in questions and weekly mood
atings are presented at the beginning of each module and submit-
ed to the patient’s therapist. These pages must be completed prior
o opening the remaining content in the module. Homework exer-
ises are assigned at the end of each module to facilitate learning33.7 (28) 38.5 (10) 38.5 (85)
 the last 159 patients.
of the material. Patients were encouraged to progress at a pace of
one module per week, although as reported below, more time was
often needed. Treatment concluded when patients withdrew from
treatment or completed the 12 modules.
Participation was  free of charge and no reimbursement was
offered for participation. Eligible patients were provided with a
username and password that allowed them to access the ICBT
program and to communicate with their therapist via a pri-
vate messaging system on a secure server. All data, messages,
check-in questions, and responses to questionnaires were stored
in a database encrypted using an industry-standard encryption
algorithm.
2.4. Therapists
Patients were assigned to community therapists working in
their local health region, or student therapists under supervision in
the Online Therapy Unit. Community therapists worked in one of
six community settings and were registered social workers or psy-
chologists with experience treating anxiety and depression using
CBT (n = 27). Student therapists were clinical psychology (n = 26)
or social work (n = 2) graduate students under supervision. All the-
rapists completed a one-day training workshop in the provision
of ICBT (Hadjistavropoulos, Thompson, Klein, & Austin, 2012) and
were then supervised. Therapists were to message their assigned
patients once a week on a set day until their patients either com-
pleted the modules or withdrew from treatment. In the emails,
therapists were instructed to provide support and encourage-
ment, answer questions regarding content, and provide feedback
on homework submitted during check-ins. Emails were estimated
to take an average of 20 min  to compose and were individualizedrapists were instructed to call the patient by phone to encourage
participation in ICBT. Therapists could also use clinical judgment to
call patients at any point to offer additional support beyond emails
(e.g., if patients reported suicidal thoughts).
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.5. Measures
Outcome was assessed using a battery of online self-report ques-
ionnaires as several studies have shown that online administration
f self-report questionnaires demonstrates adequate psychometric
roperties (e.g., Carlbring et al., 2007; Hedman et al., 2010).
The measures described below were administered at 3 time
oints including (1) after completion of the consent form, (2) after
ompletion of module 6, and (3) before completion of module 12.
The GAD-7 (Spitzer et al., 2006) asked patients how often they
ad been bothered by a list of seven problems in the past 2 weeks
nd how difﬁcult the problems had made it to do their work, take
are of things at home, or get along with other people. Each item
s rated on a 0 (not at all)  to 3 (nearly every day) scale with rat-
ngs summed for a total score ranging from 0 to 21. Spitzer and
olleagues suggested a cut-off score of 10 for identifying people
eeting diagnostic criteria for GAD. The GAD-7 has demonstrated
trong psychometric properties (Bandelow & Brasser, 2009) and 1
eek test–retest reliability was reported to be r = .83 (Spitzer et al.,
006).
The PHQ-9 (Kroenke et al., 2001) assesses for symptoms of
epression. Nine items are rated using a scale from 0 (not at all)
o 3 (nearly every day), and summed to obtain a total severity score
anging from 0 to 27. A recent meta-analysis suggested a cut-off
core of 10 or greater on the PHQ-9 results in acceptable sensitivity
nd speciﬁcity for identifying people meeting diagnostic criteria for
ajor depressive disorder (Manea, Gilbody, & McMillan, 2012). The
HQ-9 has been found to be a reliable diagnostic tool with good psy-
hometric properties (Cameron, Crawford, Lawton, & Reid, 2008;
roenke et al., 2001). Test–retest reliability assessed over 48 h was
ound to be r = .84 (Kroenke et al., 2001).
The PDSS-SR (Houck et al., 2002) consists of seven-items, each
ated on a 0–4 scale (with 0 denoting no symptoms, and higher rat-
ngs reﬂecting greater symptom severity). Items were summed to
reate a total score ranging from 0 to 28. Items assess frequency of
anic attacks, distress caused by panic, anticipatory anxiety, panic-
elated sensation fear, and work and social impairment. A cut-off
core of 9 or greater has been used to identify patients with proba-
le panic disorder (Ruwaard, Broeksteeg, Schrieken, Emmelkamp,
 Lange, 2010). The PDSS-SR has demonstrated excellent psycho-
etric properties and sensitivity to change (Houck et al., 2002).
wo-week test–retest reliability was found to be r = .84 (Newman,
olmes, Zuellig, Kachin, & Behar, 2006).
The Depression Anxiety Stress Scale-21 (DASS; Lovibond &
ovibond, 1995) was administered to assess symptoms of depres-
ion, anxiety, and stress. The 21-items are rated on a Likert scale
anging from 0 (did not apply to me at all)  to 3 (applied to me very
uch, most of the time). Totals for each scale are doubled, with
igher scores reﬂecting greater levels of pathology. Lovibond and
ovibond (1995) classify scores from 0 to 78 as normal, 78 to 87
s mild, 87 to 95 as moderate, 95 to 98 as severe, and 98 to 100
s extremely severe. The computerized version of the DASS-21 has
een validated and demonstrates strong psychometric properties
Zlomke, 2009).
The 26-item World Health Organization Quality of Life Assess-
ent BREF (WHOQOL-BREF; Skevington, Lotfy, & O’Connell, 2004)
ssesses quality of life in four domains including physical health
e.g., sleep and pain), psychological health (e.g., self-esteem and
oncentration), social relationships (e.g., support and personal
elationships), and environment (e.g., physical safety, ﬁnancial
esources, and recreation). Questions are rated on scale ranging
rom 1 (not at all)  to 5 (an extreme amount) with higher scores indi-
ating greater quality of life. The WHOQOL-BREF has demonstrated
xcellent psychometric properties (Skevington et al., 2004).
The ﬁve-item Work and Social Adjustment Scale (WSAS; Marks,
986) assesses functional impairment using a scale ranging from 0xiety Disorders 28 (2014) 884–893 887
(not at all)  to 8 (very severely) with higher scores indicating greater
functional impairment. Evidence supports the WSAS’s reliability,
validity, and sensitivity to treatment effects (Mundt, Marks, Shear,
& Greist, 2002).
At treatment completion, treatment satisfaction was assessed
with two questions asking patients “How much did you like the
treatment program?” and “How much did you enjoy communicat-
ing with your therapist?”. These two  questions were rated on a 0
(not at all)  to 7 (very much so)  scale.
2.6. Program utilization and withdrawal
The web  application was used to track the number of: (a) patient
log-ins, (b) days from ﬁrst to last patient log-in, (c) modules patients
completed, (d) phone calls from therapist to patient, (e) messages
from therapist to patient, and (f) messages from patient to therapist.
If patients withdrew from ICBT, patients were contacted by phone
and asked to complete the outcome measures described above. Rea-
son for withdrawal was also coded at this time based on this patient
contact and included: (a) patient reported a signiﬁcant reduction in
symptoms; (b) patient accessing face-to-face treatment; (c) patient
experiencing other problems/issues that interfered with treatment
(e.g., death in family, moving); (d) patient too busy to complete all
12 modules; (e) patient not ﬁnding ICBT suitable; or (f) unknown
reason as patient could not be contacted.
2.7. Data analytic approach
We ﬁrst conducted analyses to evaluate the effect of ICBT on gen-
eral outcome measures of depression, anxiety, stress, impairment,
and quality of life (i.e., DASS, WHOQOL-BREF, WSAS respectively)
for the total sample. We then conducted separate analyses for each
patient-group (i.e., generalized anxiety, depression, panic) using
disorder-speciﬁc measures (i.e., GAD-7, PHQ-9, PDSS-SR).
The general outcome measures were analyzed using latent
growth curve modeling (Bollen & Curran, 2006). Time was  speciﬁed
as linear over the active treatment phase (pre-, mid-, post-
treatment) in the growth models and residual variances were held
equal across time (i.e., identity structure). To account for non-
independence of observations (i.e., correlations among repeated
measurements), a random intercept and slope were retained when-
ever they signiﬁcantly contributed to the model and random
parameters were allowed to be correlated (i.e., unstructured covari-
ance matrix for random effects).
Models were ﬁtted with full information maximum likelihood
robust estimation using the Mplus software (vs. 5.2; Muthén &
Muthén, 2007). Maximum likelihood uses all available data in
the estimation process and borrows information from patients
with incomplete data to improve the accuracy of the parame-
ter estimates (Bollen & Curran, 2006; Enders, 2010). Following
the principle of intention-to-treat, our data analytic approach
retained individuals with at least one valid data point in the anal-
ysis. Likelihood-based methods provide unbiased estimates and
standard errors under a fairly lenient missing data assumption (e.g.,
Enders, 2010; Enders, 2011; Enders & Bandalos, 2001) formally
known as missing at random (MAR). This allowed the propensity of
missing values to be a function of observed variables in the model
(e.g., outcome scores from previous assessments; Enders, 2010).
To supplement the above analyses, additional analyses were
conducted to better understand patients who withdrew from ICBT.
First, for patients who completed outcome measures at the time
of withdrawal, paired sample t-tests were used to examine change
in scores from pre-treatment to withdrawal. Second, we examined
the frequency of reasons noted for withdrawal from treatment.
To evaluate the inﬂuence of missing data (at post-treatment) on
the ﬁndings, a sensitivity analysis in the form of a pattern mixture
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odel (also known as missing not at random (NMAR) growth
odel) was performed (Hedeker & Gibbons, 1997). Patients were
tratiﬁed into subgroups according to their missing data pattern
i.e., missing values at post-treatment). Separate growth models
ere estimated for each subgroup (similar to multiple-group anal-
sis) and population parameter values were obtained by averaging
roportion-weighted estimates across subgroups (Enders, 2011).
hese weighted-mean estimates were then compared with the
stimates obtained from the analyses that assumed that data were
issing due to ignorable reasons (i.e., MAR-assumption).
An estimated mean raw difference between pre- and post-
reatment with its associated standard error was  computed as a
unction of estimated parameters in the model (through the Model
onstraint command in Mplus). A standardized mean difference
ffect size (d) was calculated using the baseline standard deviation
s the denominator and then converted to a standardized repeated-
easures effect size (within-group d) (Morris & DeShon, 2002; Eq.
12)). Statistical signiﬁcance was determined by the Wald ratio
estimate/standard error) with an alpha level of .05 (i.e., z-value
bove 1.96). Conﬁdence intervals are given with 95% margin.
. Results
.1. Baseline characteristics
Table 1 shows baseline characteristics of patients in each ICBT
rogram. Patients were on average in their early 40 s, female, Cau-
asian, married, reporting at least completion of high school, and
ome form of employment. Most patients also reported taking some
ype of psychotropic medication.
.2. Treatment usage and satisfaction
The descriptive statistics for treatment compliance and satisfac-
ion for each program are presented in Table 2. The programs were
xtensively used by patients as indicated by the mean number of
rogram visits, messages from patient to therapist and from thera-
ist to patient. On average, patients reported very high satisfaction
atings, for both their overall satisfaction and their communications
ith their therapists.
.3. Missing data
Fig. 1 shows the patient ﬂow from pre-, mid-, to post-treatment.
ata completion varied somewhat between measures. On the
ASS, WSAS, and WHOQOL-BREF, 95.5% (n = 211) of patients pro-
ided at least one valid observed data point over the pre- to
ost-treatment period. The missing data pattern was monotone
able 2
rogram utilization and messages.
Generalized anxiety (n = 112) 
M (SD) Range 
Days between ﬁrst and last log-in 135.31 (85.93) 0–533 
Number of log-ins 39.91 (29.09) 0–170 
Number of modules completed 8.59 (4.19) 0–12 
Messages from patient to therapist 9.64 (10.53) 0–76 
Messages from therapist to patient 19.98 (11.94) 1–60 
Phone calls to patient by therapist 1.92 (2.73) 0–16 
Treatment satisfaction
Generalized anxi
How much do you like the treatment program? 5.79(1.25) 
How  much do you enjoy communicating with your therapist? 5.61(1.59) 
ote. Satisfaction ratings were made on a 0 (not at all) to 7 (very much so) scale.xiety Disorders 28 (2014) 884–893
(Enders, 2010). For example, on the DASS, 53.3% (n = 113) com-
pleted all assessments (pre-, mid-, and post-treatment), 18.4%
(n = 39) completed pre-treatment and mid-treatment assessments,
and 28.3% (n = 60) completed pre-treatment assessment only.
Among those who were offered ICBT for depression, generalized
anxiety, or panic, 96.4% (n = 80), 95.5% (n = 107), and 96.2% (n = 25)
of patients provided at least one valid observed data point during
the pre- to post-treatment assessment period on the PHQ-9, GAD-7,
and PDSS-SR, respectively.
To determine whether missing data at post-treatment was
related to background variables assessed at pre-treatment, mul-
tiple logistic regression analysis was performed. Younger age
was associated with higher probability of missing data at post-
treatment, B = −0.04, SE = 0.01, p = .004, OR = 0.96, 95% CI [0.94,
0.99]. Patients with a university degree were also less likely to have
missing data at post-treatment, as compared to those with no such
degree, B = −0.69, SE = 0.32, p = .029, OR = 0.50, 95% CI [0.27, 0.93].
None of the other examined background variables were related to
missing data (i.e., sex, employment, living alone, having children,
medication use, other medical condition). In subsequent outcome
analyses, we relied on full information maximum likelihood esti-
mation under the assumption of data MAR  (with the exception
for the pattern mixture model analysis). Patients who  provided at
least one valid observation were retained in the intention-to-treat
analyses (i.e., main continuous outcome analyses) and contributed
information to parameter estimates and associated standard errors.
3.4. Effects on depression, anxiety, stress, quality of life, and
impairment for the total sample
Estimated means and standard deviations for the DASS,
WHOQOL-BREF, and WSAS are presented in Table 3. Linear growth
curve models were estimated to evaluate the effect of time
from pre- to post-treatment on these general outcome meas-
ures. There was a statistically signiﬁcant decrease in depressive,
anxiety, and stress symptoms as measured with DASS-subscales
from pre- to post-treatment for the total sample: DASS-depression,
B = −4.30, SE = 0.43, p < .001, d = 0.78, 95% CI [0.60, 0.95]; DASS-
anxiety, B = −3.08, SE = 0.34, p < .001, d = 0.65, 95% CI [0.52, 0.78];
and DASS-stress, B = −3.79, SE = 0.38, p < .001, d = 0.78, 95% CI [0.62,
0.94].
There was  also a statistically signiﬁcant increase in quality of
life as measured with WHOQOL-BREF: physical health, B = 0.29,
SE = 0.04, p < .001, d = 0.66, 95% CI [0.48, 0.85]; psychological health,
B = 0.25, SE = 0.04, p < .001, d = 0.51, 95% CI [0.33, 0.68]; social rela-
tionships, B = 0.38, SE = 0.07, p < .001, d = 0.48, 95% CI [0.31, 0.65];
and environment, B = 0.24, SE = 0.04, p < .001, d = 0.55, 95% CI [0.38,
0.72]. There was a signiﬁcant decrease in functional impairment
Depression (n = 83) Panic (n = 26)
M (SD) Range M (SD) Range
127.33 (77.85) 0–402 121.81 (65.53) 5–246
41.27 (34.6) 0–176 50.23 (41.16) 5–149
8.42 (4.12) 0–12 8.92 (4.32) 0–12
11 (12.02) 0–69 10.65 (11.06) 0–43
19.43 (11.31) 0–62 19.81 (14.89) 1–69
2.02 (2.31) 0–10 2.46 (2.25) 0–9
ety (n = 57) Depression (n = 41) Panic (n = 13)
2–7 5.12(1.18) 1–7 6.08(1.44) 3–7
0–7 5.02(1.85) 0–7 6.15(1.21) 3–7
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s measured by the WSAS for the total sample, B = −6.34, SE = 0.70,
 < .001, d = 0.78, 95% CI [0.60, 0.97].
.5. Effects on disorder-speciﬁc outcomes
To evaluate the effect of treatment for each patient group sep-
rately, we stratiﬁed the sample based on program participation
i.e., depression, GAD, and panic) and estimated a linear growth
odel for each sub-sample using the disorder-speciﬁc outcome
easures (i.e., PHQ-9, GAD-7, and PDSS-SR) as the dependent vari-
ble. Estimated means and standard deviations as a function of
isorder-speciﬁc outcomes are presented in Table 4. Patients in the
epression program who provided at least one valid data point on
he PHQ-9 (n = 80) demonstrated a statistically signiﬁcant reduc-
ion in depressive symptoms, B = −7.68, SE = 0.82, p < .001, d = 1.25,
5% CI [0.90, 1.60]. Similarly, patients in the GAD program who
rovided at least one valid data point on the GAD-7 (n = 107)
emonstrated a signiﬁcant reduction in generalized anxiety symp-
oms, B = −5.97, SE = 0.54, p < .001, d = 1.07, 95% CI [0.85, 1.30]. There
able 3
odel-implied means and standard deviations from growth curve analyses.
Measure Pre Mid  Post
M SD M SD M SD
DASS (n = 212)
Depression 9.12 6.03 6.97 6.03 4.82 6.03
Anxiety 5.88 4.55 4.34 3.70 2.81 3.35
Stress 9.24 4.82 7.34 4.22 5.44 3.97
WHOQOL-BREF (n = 211)
Physical health 2.79 0.47 2.93 0.46 3.08 0.50
Psychological health 2.89 0.58 3.02 0.55 3.14 0.59
Social relationships 2.81 0.91 3.00 0.91 3.19 0.91
Environment 3.64 0.62 3.75 0.62 3.87 0.62
WSAS (n = 211) 18.86 9.10 15.68 9.10 12.51 9.10
ote. Results are based on a linear growth curve model with random effects and
esidual variances constrained to be equal across time. DASS, The Depression Anx-
ety  Stress Scale; WHOQOL-BREF, The World Health Organization Quality of Life
ssessment BREF; WSAS, The Work and Social Adjustment Scale. from pre-treatment to post-treatment.
was also a signiﬁcant reduction in panic symptoms as measured
with PDSS-SR for patients who were offered the panic program and
who provided at least one valid data point on the measure (n = 25),
B = −8.09, SE = 1.90, p < .001, d = 0.91, 95% CI [0.38, 1.43].
3.6. Patient withdrawal
The 99 patients who  withdrew from treatment completed
an average of 5.44 (SD = 2.98) modules over the course of 4.64
months (SD = 2.92). They logged in 26.65 (SD = 25.69) times, sent
6.54 (SD = 8.43) emails, and received 15.53 (SD = 1.66) emails and
2.34 (SD = 2.54) phone calls from their therapists. Approximately
26% (n = 26) of these patients completed symptom measures at
the time they withdrew from treatment. Paired sample t-tests
showed that patients who withdrew reported signiﬁcant improve-
ment from pre-treatment to withdrawal on the symptom measures
(see Table 5). Examination of reasons for withdrawal revealed that
22.2% (n = 22) patients reported withdrawing because their primary
symptoms had improved. Other reasons for withdrawal included
patients reporting that they were now able to access face-to-face
therapy (15.2%; n = 15), they were too busy to complete all 12
modules (9.1%; n = 9), or they were experiencing other issues that
Table 4
Model-Implied Means and Standard Deviations for Disorder-Speciﬁc Outcomes as
Function of Patient Group.
Measure Pre Mid  Post
M SD M SD M SD
PHQ-9 (Depression,
n = 80)
14.75 5.56 10.91 5.17 7.07 5.80
GAD-7 (Generalized
anxiety, n = 107)
11.92 5.27 8.94 4.45 5.95 3.94
PDSS-SR (Panic, n = 25) 13.10 6.45 9.05 5.12 5.01 6.00
Note. Results are based on a linear growth curve model with random effects and
residual variances constrained to be equal across time. PHQ-9, Patient Health
Questionnaire-9; GAD-7, Generalized Anxiety Disorder-7; PDSS-SR, Panic Disorder
Severity Scale-Self Report.
890 H.D. Hadjistavropoulos et al. / Journal of An
Table 5
Means and standard deviations from pre-treatment to time of withdrawal for
patients who  withdrew from treatment (n = 26).
Measure Pre-Treatment Withdrawal t
M SD M SD
DASS Depression 8.27 6.29 5.58 5.92 2.24*
DASS Anxiety 5.50 3.93 2.96 4.09 3.16**
DASS Stress 9.27 4.98 5.88 5.16 3.52**
PHQ-9 11.96 5.98 6.69 5.60 5.10**
GAD-7 10.46 5.44 5.62 5.54 4.56**
Note. DASS, The Depression Anxiety Stress Scale; PHQ-9, Patient Health
Q
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auestionnaire-9; GAD-7, Generalized Anxiety Disorder-7.
* p < .05.
** p < .01
nterfered with treatment (e.g., death in the family, moving out of
rovince; 8.1%). It was rare for patients to indicate that they were
ot beneﬁtting from the program (3%; n = 3). In 42.4% (n = 42) of
ases, the patient could not be contacted and no reason for with-
rawal was provided.
.7. The inﬂuence of missing data
To explore whether outcome-dependent missing data (i.e.,
MAR) inﬂuenced the ﬁndings, we conducted a sensitivity analy-
is using a pattern mixture model (Enders, 2011) with DASS as the
ependent variable. We  stratiﬁed the sample into two  subgroups;
peciﬁcally patients with missing data at post-treatment were com-
ined into a missing data group (n = 99) and a no missing data group
n = 113). A separate linear growth model was estimated for each
ub-sample and growth factor means (intercept and slope) were
reely estimated in each subgroup. Variance estimates were held
qual across subgroups. Proportion-weighted mean estimates (i.e.,
aw mean difference between pre and post-treatment) were then
veraged over subgroups to obtain corrected population parameter
stimates. These results were compared with the results from the
nalyses on DASS that assumed that data loss was ignorable (i.e.,
AR).
Results from the pattern mixture models revealed no evidence
hat missing data inﬂuenced the ﬁndings on DASS-stress or DASS-
nxiety. That is, there were no signiﬁcant differences between
hose who completed the post-treatment assessment and those
ho did not in terms of average rate of growth over the active
reatment phase. Further, the corrected proportion-weighted mean
stimates of difference between pre- and post-treatment were sim-
lar to those reported earlier. However, there was  some evidence
hat outcome-dependent missing data may  have inﬂuenced the
ndings with regard to the DASS-depression subscale. Patients
ith missing data had a slower rate of change as compared
ith patients who completed the assessment at post-treatment,
 = −1.17, SE = 1.52 and B = −4.39, SE = 0.48, respectively. In addi-
ion, the proportion-weighted population parameter estimate (i.e.,
ean difference from pre- to post-treatment) obtained in the pat-
ern mixture model was slightly lower than the estimate obtained
n the MAR-based growth model (−2.89 vs. −4.30). Still, the mean
ifference remained highly signiﬁcant (p < .001) in the pattern mix-
ure model and the standardized effect size was d = 0.49. Thus,
lthough MAR-based growth curve analyses reported earlier may
ave overestimated treatment effects to some degree, the over-
ll conclusions remained qualitatively similar across models with
ifferent missing data assumptions.. Discussion
Although the efﬁcacy of therapist-assisted ICBT for depression
nd anxiety has been ﬁrmly established (e.g., Hedman, Ljotsson, &xiety Disorders 28 (2014) 884–893
Lindefors, 2012), there is an insufﬁcient evidence-base for the effec-
tiveness of ICBT when delivered in routine clinical practice. In an
effort to disseminate controlled research into clinical practice, we
examined the effectiveness of three ICBT programs that were coor-
dinated by a centralized unit across multiple sites and delivered by
community providers and supervised graduate students new to the
delivery of ICBT.
With almost 400 patients expressing interest in ICBT and over
200 patients participating in one of three programs, there was sub-
stantial interest in ICBT. It is notable, that while 60% of patients
were appropriate for treatment, approximately 40% of patients
who were initially screened were excluded from treatment. There
were multiple reasons for this exclusion. Most commonly, indi-
viduals were curious about the treatment, but did not complete
the screening (39%). In other instances, patients were excluded
because their conditions (e.g., mania) were deemed to require
more intensive services (20%), they were already in receipt of
face-to-face treatment (16%), symptoms were considered to be too
mild to justify therapist-assisted ICBT (12%), or patients did not
meet important inclusion criteria such as age, residency and com-
puter/Internet access (12%). The exclusion criteria used in this unit
were consistent with past studies (Andrews et al., 2010). Given the
signiﬁcant number of individuals interested in treatment who  were
excluded, however, further attention should be given to the appro-
priateness of the exclusion criteria in clinical practice, especially
when patients could be more easily moved from ICBT to face-to-
face treatment if difﬁculties arose. It is particularly noteworthy
that patients who had mild symptoms and patients who were
already accessing face-to-face treatment expressed an interest in
ICBT.
In terms of outcomes, consistent with efﬁcacy trials, the results
of this study are promising and suggest that, when delivered
in clinical practice, ICBT is effective in treating patients with
symptoms of depression, generalized anxiety, or panic. With
moderate effect sizes, patients across all programs reported sig-
niﬁcant improvements in depression, anxiety, stress, quality of
life, and work and social adjustment. When stratiﬁed by pro-
gram, improvements on disorder-speciﬁc measures were large
(d = .91–1.25). Patient satisfaction with ICBT was also very high.
These results are particularly encouraging given that all the
therapists were newly trained in the provision of ICBT and treat-
ment was delivered from six separate sites coordinated by a
centralized unit.
Of particular importance for others who are interested in the
implementation of ICBT in clinical practice, we found only 53% of
patients completed all 12 modules and the ﬁnal outcome meas-
ures. The pressing question is what impact did ICBT have on those
patients who  withdrew from treatment? Follow-up measures com-
pleted by 26% of the patients who withdrew revealed that they
experienced signiﬁcant improvement in symptoms, suggesting we
were offering more treatment than was necessary and desired.
Past authors have also identiﬁed that a proportion of patients who
withdraw from ICBT experience signiﬁcant symptom improvement
prior to drop-out, suggesting that non-completion should not nec-
essarily be regarded as a treatment failure (Newby et al., 2013;
Williams & Andrews, 2013). Other patients withdrew once they
were able to access face-to-face therapy (e.g., they had been on
a waiting list), because they were too busy to complete all mod-
ules, or other issues came up that interfered with treatment (e.g.,
moving out of province). It was  very rare for patients to explic-
itly report not beneﬁtting from treatment. We  were not able to
identify why  22% of the entire sample of treated patients withdrew
from treatment. It is possible that these patients were nonrespon-
ders or low responders. This would be consistent with a study of
trajectory of change over the course of ICBT, where it was  found
that 75–80% of patients respond to ICBT and 20–25% of patients
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re low responders (Sunderland, Wong, Hilvert-Bruce, & Andrews,
012).
Examination of treatment adherence data was also enlighten-
ng. Overall, when ICBT was provided in clinical practice, it appears
hat patients were highly engaged in the treatment. On average,
atients completed 8.6 of the 12 modules and logged into the pro-
ram 42 times during a 4-month period. In addition to completing
eekly check-ins with each module, they messaged their therapist
n average 10 times. Therapists, in turn, provided considerable sup-
ort to patients sending, on average, 20 messages over the course
f treatment. Phone calls were less frequent, with most patients
alled on average only twice by their therapist; phone calls were
ost commonly made to bolster client motivation and or assess
atient risk. Even patients who withdrew from treatment were
igniﬁcantly engaged in treatment; indeed, on average they com-
leted 5.44 modules, logged in 26 times, and remained engaged
n treatment for approximately 4 months. This level of engage-
ent suggests that noncompletion of all ICBT modules need not
ecessarily be considered as a treatment failure.
In our clinical experience, it is not uncommon for clinicians
o comment that patients who are attracted to ICBT are different
han patients who attend face-to-face treatment. Of note, how-
ver, patients in this study appear to be similar to patients who use
ace-to-face psychological services; indeed, similar to face-to-face
ervices, most patients were female, middle aged, and indicated
 higher level of education than is generally found in the popula-
ion (Hunsley, Aubry, Verstervelt, & Vito, 1999). It was encouraging
o ﬁnd that almost half of the patients resided in smaller cities,
owns, and rural areas of Saskatchewan. This could indicate that
CBT is appealing to patients residing in areas where mental health
reatment is more limited compared to resources available in larger
rban centers. Given the limited ethnic diversity of this sample,
here is a need for further research on strategies to encourage use
f ICBT by more diverse patient groups.
The results of the study need to be considered in light of study
imitations. First, as noted above, only 53% of patients completed
he outcome measures at the end of treatment. Of those who
ithdrew, only 26% completed outcome measures at the time of
ithdrawal. This leaves us with an incomplete understanding of
he impact of ICBT for patients who do not complete outcome
easures. This is a similar problem reported by others who  have
ffered ICBT in clinical practice (Mewton, Wong, & Andrews, 2012;
ewby et al., 2013; Williams & Andrews, 2013). When estimating
he effectiveness of ICBT in clinical practice, statistical procedures
ere used in order to take into account the missing post-treatment
ata. These statistical procedures represent the state of the art for
tatistical inferences in the presence of incomplete data under the
ess restrictive, often very reasonable, MAR  assumption (Enders,
010). Researchers have found, for instance, that analyses assuming
AR  appear to provide unbiased estimates even when substantial
ata are missing (e.g., Salim, Mackinnon, Christensen, & Grifﬁths,
008). Moreover, sensitivity analyses, in which it was  assumed
hat missingness was related to the outcome variable itself at
ost-assessment (i.e., NMAR assumption), provide no substantial
vidence to suggest that missing data inﬂuenced the ﬁndings. Nev-
rtheless, all missing data analyses rely on untestable assumptions
nd no deﬁnitive conclusions can be drawn about the extent to
hich missing data inﬂuenced the ﬁndings. Given this, the effec-
iveness of ICBT in clinical practice in this study (and others with
ow completion rates) needs to be interpreted cautiously. It is
ncumbent upon researchers to strive to improve outcome mea-
ure completion rates so as to have the best understanding of ICBT
n clinical practice and advance the ﬁeld.
Of note, in this study, examination of missing data itself was
nteresting. We  found, for instance, that patients who reported
 younger age and lower education were the most likely to havexiety Disorders 28 (2014) 884–893 891
missing outcome data. Williams and Andrews (2013) and Mewton
et al. (2012) similarly have found that younger age was associated
with noncompletion of ICBT and have speciﬁcally suggested that
treatment programs may  require tailoring in order to meet the
needs of younger patients (e.g., greater attention to issues that are
common among younger adults). The current study suggests that
perhaps tailoring is also needed for patients with lower education
in order to enhance program completion.
Beyond missing data, this study was also limited because
resources and the clinical setting precluded a comparison group.
The impact of natural remission or placebo response, therefore,
over the treatment period cannot be separated from the responses
to the speciﬁc ICBT programs. Utilizing a waiting list control con-
dition was not used as it has been described by some as ethically
questionable in the context of community based care (Devilly &
McFarlane, 2009) and would also have represented a departure
from the naturalistic methodology desirable for this study. In light
of the comparability of ﬁndings to clinical trials, it is most likely
the treatment effects are attributable to ICBT. A ﬁnal notable limi-
tation is that restricted resources limited the collection of follow-up
data, thus preventing the ability to determine the effectiveness
of ICBT over a longer duration. Past randomized controlled tri-
als, however, have consistently shown that symptom reductions
are still maintained at a median follow-up of 26 weeks (Andrews
et al., 2010). Interestingly, a recent randomized non-inferiority
trial suggested that individuals who received face-to-face cogni-
tive behavior therapy for depression showed worsening symptoms
after 3 months while those receiving ICBT did not (Wagner, Horn, &
Maercker, 2013). In another study with a similar design, there was
even a tendency for the therapist-assisted ICBT group to be supe-
rior to group-based cognitive behavior therapy at 3-year follow-up
(Andersson et al., 2013). It is possible that because ICBT pro-
vides motivated individuals with direct and convenient access to
evidence-based therapeutic information and tools, this approach
may encourage and enhance self-responsibility and thus contribute
to stability of outcomes (Wagner et al., 2013).
In terms of future directions, given that patients completed
approximately 8 of 12 modules, and that patients who completed
all 12 modules, on average, were followed by therapists for approx-
imately 4 months (a longer period than resources currently allow),
we are exploring the effectiveness of a briefer transdiagnostic ICBT
program for symptoms of depression and anxiety. We  will con-
tinue to follow the same coordinated care model; but, patients
will be offered ﬁve main modules addressing core cognitive and
behavioral skills with supplementary materials available for those
who desire additional resources (program described by Dear et al.,
2011). Recent research suggests that a brief transdiagnostic ICBT
program for anxiety and depression results in large effects (Dear
et al., 2011; Titov, Andrews, Johnston, Robinson, & Spence, 2010;
Titov et al., 2011). Community clinicians are particularly interested
in this approach as it is perceived to require less time to deliver
than separate disorder-speciﬁc programs, and could be particularly
advantageous for patients with comorbid anxiety and depression.
In studying the effectiveness of transdiagnostic ICBT, we recog-
nize the importance of examining longer-term beneﬁts as well as
the cost-effectiveness of this treatment. Consistent with our inter-
est in integrating ICBT within clinical practice, in the future, we
also intend to explore the effectiveness of ICBT when offered as an
adjunct to face-to-face treatment for patients who  are considered
too severe for ICBT alone (e.g., when suicidal ideation is present).
To further streamline patient ﬂow into ICBT within the community
settings, we  are creating an online screening tool and are devel-
oping resources to improve patient understanding of ICBT prior
to enrolment. Additionally, we are also exploring various meth-
ods of improving patient completion of outcome measures, which
is traditionally very difﬁcult in clinical settings where the focus is
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n clinical care rather than research (e.g., automated messages to
atients; clearer statements to patients and providers regarding
he importance of completing outcome measures).
. Conclusion
While countries such as Sweden, Australia, and the Netherlands
re increasingly offering ICBT in clinical practice, provision of
herapist-assisted ICBT in Canada has been infrequent. The ﬁndings
f this study are promising and are expected to have an impact on
oth clinicians and health system decision-makers. Dissemination
rojects, such as this one, are valuable as they serve to demonstrate
he applicability of ICBT to the Canadian context. The study also
erves to highlight important issues for consideration in delivering
CBT in clinical practice, such as whether the same exclusion crite-
ia should be applied in clinical practice as research trials and the
mportance of gathering outcome data from all patients regardless
f program completion, despite the added challenges associated
ith this task in clinical practice. While additional research is
eeded in this area to further improve the implementation of
CBT in clinical practice, the present research illustrates that many
atients were interested in this service, engaged with the treat-
ent, experienced large improvements, and reported high levels
f satisfaction. The results are particularly encouraging in that they
ere obtained when therapists were new to the provision of ICBT.
his study also serves to highlight a unique model of coordinat-
ng ICBT that may  be of interest to other organizations, whereby
herapist-assisted ICBT was coordinated by a centralized unit with
reatment offered by community therapists and graduate students
orking in diverse geographically dispersed settings.
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